Evidence map›Paper›PMID 25886831›Full record

ArticlePsychosomatic medicine2015

Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation.

Janine Giese-Davis, Frank H Wilhelm, Rie Tamagawa, Oxana Palesh, Eric Neri, Craig Barr Taylor, Helena C Kraemer, David Spiegel

Abstract read
In one paragraph

Article in Psychosomatic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Secondary outcomes of a behavioral sleep intervention: A randomized clinical trial.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2019
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Review
  12. Key role of the autonomic nervous system in breast cancer (Review).Experimental and therapeutic medicine · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. A dyadic stress induction tool for experimental investigation of adult patients with cancer and their family caregivers.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Janine Giese-DavisFrom the Department of Oncology (Giese-Davis, Tamagawa), Division of Psychosocial Oncology, University of Calgary, Calgary, Alberta, Canada; Tom Baker Cancer Centre (Giese-Davis, Tamagawa), Psychosocial Resources, Calgary, Alberta, Canada; Department of Psychiatry and Behavioral Sciences (Giese-Davis, Palesh, Neri, Taylor, Kraemer, Spiegel), Stanford University School of Medicine, Stanford, CA; and Department of Psychology (Wilhelm), Division of Clinical Psychology, Psychotherapy, & Health Psychology, University of Salzburg, Salzburg, Austria.
Frank H Wilhelm
Rie Tamagawa
Oxana Palesh
Eric Neri
Craig Barr Taylor
Helena C Kraemer
David Spiegel

Funding

XOLAIR IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH FOOD ALLERGYM01RR000070 · NCRR · STANFORD UNIVERSITY · PI VAN MEURS, KRISA PAGE · 1985 to 2008
$32.4M
Stress, The HPA and Health in AgingP01AG018784 · NIA · STANFORD UNIVERSITY · PI SPIEGEL, DAVID · 2001 to 2008
$8.7M
Brief Behavioral Intervention for Insomnia During ChemotherapyR01CA181659 · NCI · STANFORD UNIVERSITY · PI PALESH, OXANA G · 2014 to 2018
$3.1M
Impact of Affect Reactivity and Regulation on Breast Cancer Treatment DecisionsU01CA197282 · NCI · STANFORD UNIVERSITY · PI GROSS, JAMES J, SPIEGEL, DAVID · 2015 to 2019
$3.1M
NCI NIH HHS R01 CA181659NCI NIH HHS U01 CA197282NCRR NIH HHS 5 M01 RR000070NCRR NIH HHS M01 RR000070NIA NIH HHS AG18784NIA NIH HHS P01 AG018784
6 · The paper itself

Abstract

objectiveHigh levels of high-frequency heart rate variability (HF-HRV), related to parasympathetic-nervous-system functioning, have been associated with longer survival in patients with myocardial infarction and acute trauma and in patients undergoing palliative care. From animal studies linking higher vagal activity with better immune system functioning and reduced metastases, we hypothesized that higher HF-HRV would predict longer survival in patients with metastatic or recurrent breast cancer (MRBC).

methodsEighty-seven patients with MRBC participated in a laboratory task including a 5-minute resting baseline electrocardiogram. HF-HRV was computed as the natural logarithm of the summed power spectral density of R-R intervals (0.15-0.50 Hz). In this secondary analysis of a study testing whether diurnal cortisol slope predicted survival, we tested the association between resting baseline HF-HRV on survival using Cox proportional hazards models.

resultsA total of 50 patients died during a median follow-up of 7.99 years. Higher baseline HF-HRV predicted significantly longer survival, with a hazard ratio of 0.75 (95% confidence interval = 0.60-0.92, p = .006). Visceral metastasis status and baseline heart rate were related to both HF-HRV and survival. However, a combination of HF-HRV and heart rate further improved survival prediction, with a hazard ratio of 0.64 (95% confidence interval = 0.48-0.85, p = .002).

conclusionsVagal activity of patients with MRBC strongly predicted their survival, extending the known predictive window of HF-HRV in cancer beyond palliative care. Vagal activity can be altered by behavioral, pharmacological, and surgical interventions and may be a promising target for extending life expectancy in patients with metastasizing cancer.

Indexed as

Survival AnalysisAdultAgedAutonomic Nervous SystemBreast NeoplasmsFemaleFollow-Up StudiesHeart RateHumansMiddle AgedNeoplasm MetastasisNeoplasm Recurrence, LocalVagus Nerve

Identifiers

PMID25886831
PMCPMC5509754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.